NH
Income statement / Annual
Last year (2022), NantHealth, Inc.'s total revenue was $67.00 M,
an increase of 6.95% from the previous year.
In 2022, NantHealth, Inc.'s net income was -$67.78 M.
See NantHealth, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$67.00 M
|
$62.65 M
|
$73.17 M
|
$95.96 M
|
$89.46 M
|
$86.68 M
|
$100.38 M
|
$58.30 M
|
$33.92 M
|
| Cost of Revenue |
$28.84 M |
$27.81 M |
$29.23 M |
$38.42 M |
$44.27 M |
$41.52 M |
$72.33 M |
$34.81 M |
$24.23 M |
| Gross Profit |
$38.16 M |
$34.84 M |
$43.95 M |
$57.54 M |
$45.20 M |
$45.15 M |
$28.05 M |
$23.50 M |
$9.69 M |
| Gross Profit Ratio |
0.57 |
0.56 |
0.6 |
0.6 |
0.51 |
0.52 |
0.28 |
0.4 |
0.29 |
| Research and Development
Expenses |
$23.05 M
|
$19.71 M
|
$17.27 M
|
$19.07 M
|
$20.92 M
|
$33.86 M
|
$61.64 M
|
$23.84 M
|
$16.98 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$62.50 M
|
$52.09 M
|
$48.53 M
|
$61.04 M
|
$70.76 M
|
$74.98 M
|
$120.65 M
|
$69.02 M
|
$46.21 M
|
| Other Expenses |
$3.94 M |
$3.94 M |
$3.68 M |
$4.22 M |
$4.22 M |
$800,000.00 |
$1.92 M |
$2.51 M |
-$477,000.00 |
| Operating Expenses |
$89.49 M |
$75.74 M |
$69.48 M |
$84.33 M |
$95.90 M |
$113.05 M |
$189.55 M |
$94.40 M |
$70.22 M |
| Cost And Expenses |
$118.33 M |
$103.55 M |
$98.71 M |
$122.75 M |
$140.17 M |
$154.58 M |
$261.88 M |
$129.21 M |
$94.45 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$14.12 M |
$14.48 M |
$19.20 M |
$18.04 M |
$17.12 M |
$16.17 M |
$6.34 M |
$627,000.00 |
$980,000.00 |
| Depreciation &
Amortization |
$13.34 M
|
$853,000.00
|
-$38.85 M
|
-$9.73 M
|
-$122.07 M
|
$4.22 M
|
$7.26 M
|
$15.79 M
|
$16.18 M
|
| EBITDA |
-$37.99 M
|
-$40.90 M
|
-$26.27 M
|
-$30.77 M
|
-$172.77 M
|
-$67.90 M
|
-$161.50 M
|
-$55.19 M
|
-$43.30 M
|
| EBITDA Ratio |
-0.57 |
-0.64 |
-0.88 |
-0.38 |
-1.93 |
-1.31 |
-1.93 |
-0.95 |
-1.28 |
| Operating Income Ratio
|
-0.77
|
-0.65
|
-0.35
|
-0.28
|
-0.57
|
-0.78
|
-1.61
|
-1.22
|
-2.5
|
| Total Other
Income/Expenses Net |
-$16.77 M
|
-$17.57 M
|
-$62.45 M
|
-$35.96 M
|
-$143.41 M
|
-$65.70 M
|
-$45.41 M
|
-$703,000.00
|
$68,000.00
|
| Income Before Tax |
-$68.10 M |
-$58.47 M |
-$87.99 M |
-$62.76 M |
-$194.11 M |
-$133.60 M |
-$206.91 M |
-$71.61 M |
-$84.61 M |
| Income Before Tax Ratio
|
-1.02
|
-0.93
|
-1.2
|
-0.65
|
-2.17
|
-1.54
|
-2.06
|
-1.23
|
-2.49
|
| Income Tax Expense |
-$317,000.00 |
$97,000.00 |
$447,000.00 |
-$112,000.00 |
-$3.67 M |
-$2.20 M |
-$22.81 M |
$405,000.00 |
$5,000.00 |
| Net Income |
-$67.78 M |
-$58.57 M |
-$88.44 M |
-$62.64 M |
-$190.43 M |
-$175.21 M |
-$184.10 M |
-$72.01 M |
-$84.43 M |
| Net Income Ratio |
-1.01 |
-0.93 |
-1.21 |
-0.65 |
-2.13 |
-2.02 |
-1.83 |
-1.24 |
-2.49 |
| EPS |
-8.8 |
-7.7 |
-11.96 |
-8.52 |
-26.17 |
-22.51 |
-24.74 |
-8.95 |
-10.49 |
| EPS Diluted |
-8.8 |
-7.7 |
-11.96 |
-8.51 |
-26.17 |
-22.51 |
-24.74 |
-8.95 |
-10.49 |
| Weighted Average Shares
Out |
$7.70 M
|
$7.61 M
|
$7.40 M
|
$7.36 M
|
$7.28 M
|
$7.78 M
|
$7.44 M
|
$8.05 M
|
$8.05 M
|
| Weighted Average Shares
Out Diluted |
$7.70 M
|
$7.61 M
|
$7.40 M
|
$7.36 M
|
$7.28 M
|
$7.78 M
|
$7.44 M
|
$8.05 M
|
$8.05 M
|
| Link |
|
|
|
|
|
|
|
|
|
